Global Tissue Diagnostics Market to Reach $4.8 Billion by 2024

ReportLinker

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares. -Market presence across multiple geographies - Strong/Active/Niche/Trivial.

New York, June 23, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Tissue Diagnostics Industry" - https://www.reportlinker.com/p05799811/?utm_source=GNW
-Online interactive peer-to-peer collaborative bespoke updates
-Access to our digital archives and MarketGlass Research Platform
-Complimentary updates for one year

Global Tissue Diagnostics Market to Reach $4.8 Billion by 2024

Tissue diagnostics is the process of testing and analysis of tissue samples by way of capturing diseases` biological context. The tests are mainly used for detecting medical conditions such as inflammatory disorders and cancers for revealing the right type of disease and also its malignancy level, which is essential for determining the right treatment options. Amid the COVID-19 crisis, the global market for Tissue Diagnostics is projected to reach US$4.8 Billion by 2024, registering a compounded annual growth rate (CAGR) of 5.6% over the analysis period. United States represents the largest regional market for Tissue Diagnostics, accounting for an estimated 34.9% share of the global total. The market is projected to reach US$1.7 Billion by the close of the analysis period. China is expected to spearhead growth and emerge as the fastest growing regional market with a CAGR of 8.7% over the analysis period.

Growth in the global market is set to be fueled by increase in cancer incidences, aging population and increasing healthcare spending by countries. General increase in diagnostic test numbers, technology advancements and increasing pharma industry investments are the other important factors behind strong growth for the global market for tissue diagnostics. Tissue diagnostics is emerging as one of the important tools for cancer management. Tissue diagnosis for cancer detection is carried out through core biopsy, fine needle aspiration cytology and open biopsy. North America represents a key regional market, led by factors such as higher cancer incidence rate, growth of personalized medicine, increased adoption of technologically more advanced tissue diagnostics, geriatric population, and high number of collaborations between biotech firms and pharmaceutical companies in the region. Growth in the Asia-Pacific region is attributable to the constantly rising need for enhanced testing, increased demand for improved facilities for patient care, and favorable regulations.

The market for Immunohistochemistry tissue diagnostic tests is forecast to dominate market share over the analysis period. IHC is applied widely in development of diagnostics as well as therapeutics for cancers and also in clinical R&D. The test is being increasingly preferred to traditional enzyme-staining techniques. Continuous innovations also create strong growth opportunities for the market. Technical advances in IHC technique have the potential to harness the wealth of contextual information contained in tissue samples. To meet the demand for precise and accurate data, next-generation IHC techniques improve the accuracy, precision, and analytical features to expedite research and improve patient care.
Select Competitors (Total 40 Featured) -

• Abbott Laboratories

• Abcam plc

• Agilent Technologies

• Becton, Dickinson and Company

• Bio SB

• Bio-Genex Laboratories

• Cell Signaling Technology, Inc.

• F. Hoffmann-La Roche Ltd

• Leica Biosystems Nussloch GmbH

• Merck KGaA

• QIAGEN N.V.

• Sakura Finetek Japan Co., Ltd.

• Thermo Fisher Scientific Inc.

Read the full report: https://www.reportlinker.com/p05799811/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Tissue Diagnostics Market: Prelude
Immunohistochemistry Emerges as the Major Tissue Diagnostic Test
Breast Cancer Leads the Application Market for Tissue Diagnostics
Hospitals Represent the Leading End-Use Segment
Developed Regions Lead, Developing Economies to Spearhead Growth
Impact of COVID-19 on Healthcare & Pharmaceutical Industries
Competition
Recent Market Activity
Tissue Diagnostics - Global Key Competitors Percentage Market
Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Rising Cancer Incidence Worldwide Spurs Demand for Tissue
Diagnostics
Global Cancer Incidence: Number of New Cancer Cases in Million
for the Years 2018, 2020, 2025, 2030, 2035 and 2040
Global Number of New Cancer Cases and Cancer-related Deaths by
Cancer Site for 2018
Number of New Cancer Cases and Deaths (in Million) by Region
for 2018
Global Number of New Cancer Cases (in Million) in Men by Cancer
Site: 2018
Global Number of New Cancer Deaths (in Million) in Men by
Cancer Site: 2018
Global Number of New Cancer Cases (in Million) in Women by
Cancer Site: 2018
Global Number of New Cancer Deaths (in Million) in Women by
Cancer Site: 2018
Aging Population and Changing Lifestyles Drive Cancer
Incidence, Fueling Prospects for Tissue Diagnostics Market
Global Aging Population: Population of 65+ Individuals
(in Thousands) by Region for 2019 and 2030
Global Population of 65+ Individuals as % of Total Population
by Region for 2019 and 2030
Elderly Population (65+ Years) as a % of Total Population by
Developed, Less Developed and Least Developed Regions: 2019 &
2030
Global Cancer Deaths by Age Group (in %) for 2019
Increasing Healthcare Spending Levels Augur Well for the Market
Global Healthcare Market Size in $ Billion for the Years 2018-2022
Healthcare Expenditure as a % of GDP by Region for 2019
Per Capita Healthcare Spending (in $) in Select Countries for
the Year 2019
Growing Significance of Personalized Medicine: An Opportunity
for Tissue Diagnostics Market
Global Personalized Medicine Market: Revenues in US$ Million
for the Years 2019 and 2024
Liquid Biopsies Grow in Value as a Diagnostic Tool Supporting
Therapy Decisions in NSCLCs
Sustained Advancements in Tissue Diagnostics Space Fuel Market
Prospects
Market Poised to Benefit from Digitalization of Tissue
Diagnostic Techniques & Automated Tissue Diagnostic Systems

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Tissue Diagnostics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Tissue Diagnostics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Tissue Diagnostics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for
Consumables by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Consumables by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Consumables by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for
Instruments by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Instruments by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Instruments by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 10: World Recent Past, Current & Future Analysis for
Immunohistochemistry by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 11: World Historic Review for Immunohistochemistry by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 12: World 15-Year Perspective for Immunohistochemistry by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 13: World Recent Past, Current & Future Analysis for in
Situ Hybridization by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 14: World Historic Review for in Situ Hybridization by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for in Situ Hybridization
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 16: World Recent Past, Current & Future Analysis for
Special Staining by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for Special Staining by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 18: World 15-Year Perspective for Special Staining by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 19: World Recent Past, Current & Future Analysis for
Digital Pathology & Workflow by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Digital Pathology &
Workflow by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Digital Pathology &
Workflow by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027

Table 22: World Recent Past, Current & Future Analysis for
Hospitals by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Hospitals by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 24: World 15-Year Perspective for Hospitals by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027

Table 25: World Recent Past, Current & Future Analysis for
Pharma Companies by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for Pharma Companies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Pharma Companies by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 28: World Recent Past, Current & Future Analysis for
Research Laboratories by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2020 through 2027 and % CAGR

Table 29: World Historic Review for Research Laboratories by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Research Laboratories
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 31: World Recent Past, Current & Future Analysis for
Other End-Uses by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2020 through 2027 and % CAGR

Table 32: World Historic Review for Other End-Uses by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 33: World 15-Year Perspective for Other End-Uses by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

III. MARKET ANALYSIS

UNITED STATES
Tissue Diagnostics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2022 (E)
Table 34: USA Recent Past, Current & Future Analysis for Tissue
Diagnostics by Product - Consumables and Instruments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 35: USA Historic Review for Tissue Diagnostics by Product -
Consumables and Instruments Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 36: USA 15-Year Perspective for Tissue Diagnostics by
Product - Percentage Breakdown of Value Sales for Consumables
and Instruments for the Years 2012, 2021 & 2027

Table 37: USA Recent Past, Current & Future Analysis for Tissue
Diagnostics by Technology - Immunohistochemistry, in Situ
Hybridization, Special Staining and Digital Pathology &
Workflow - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 38: USA Historic Review for Tissue Diagnostics by
Technology - Immunohistochemistry, in Situ Hybridization,
Special Staining and Digital Pathology & Workflow Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 39: USA 15-Year Perspective for Tissue Diagnostics by
Technology - Percentage Breakdown of Value Sales for
Immunohistochemistry, in Situ Hybridization, Special Staining
and Digital Pathology & Workflow for the Years 2012, 2021 &
2027

Table 40: USA Recent Past, Current & Future Analysis for Tissue
Diagnostics by End-Use - Hospitals, Pharma Companies, Research
Laboratories and Other End-Uses - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 41: USA Historic Review for Tissue Diagnostics by End-Use -
Hospitals, Pharma Companies, Research Laboratories and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$
Million for Years 2012 through 2019 and % CAGR

Table 42: USA 15-Year Perspective for Tissue Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Pharma Companies, Research Laboratories and Other End-Uses for
the Years 2012, 2021 & 2027

CANADA
Table 43: Canada Recent Past, Current & Future Analysis for
Tissue Diagnostics by Product - Consumables and Instruments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 44: Canada Historic Review for Tissue Diagnostics by
Product - Consumables and Instruments Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 45: Canada 15-Year Perspective for Tissue Diagnostics by
Product - Percentage Breakdown of Value Sales for Consumables
and Instruments for the Years 2012, 2021 & 2027

Table 46: Canada Recent Past, Current & Future Analysis for
Tissue Diagnostics by Technology - Immunohistochemistry, in
Situ Hybridization, Special Staining and Digital Pathology &
Workflow - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 47: Canada Historic Review for Tissue Diagnostics by
Technology - Immunohistochemistry, in Situ Hybridization,
Special Staining and Digital Pathology & Workflow Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 48: Canada 15-Year Perspective for Tissue Diagnostics by
Technology - Percentage Breakdown of Value Sales for
Immunohistochemistry, in Situ Hybridization, Special Staining
and Digital Pathology & Workflow for the Years 2012, 2021 &
2027

Table 49: Canada Recent Past, Current & Future Analysis for
Tissue Diagnostics by End-Use - Hospitals, Pharma Companies,
Research Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 50: Canada Historic Review for Tissue Diagnostics by
End-Use - Hospitals, Pharma Companies, Research Laboratories
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 51: Canada 15-Year Perspective for Tissue Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Pharma Companies, Research Laboratories and Other End-Uses for
the Years 2012, 2021 & 2027

JAPAN
Tissue Diagnostics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2022 (E)
Table 52: Japan Recent Past, Current & Future Analysis for
Tissue Diagnostics by Product - Consumables and Instruments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 53: Japan Historic Review for Tissue Diagnostics by
Product - Consumables and Instruments Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 54: Japan 15-Year Perspective for Tissue Diagnostics by
Product - Percentage Breakdown of Value Sales for Consumables
and Instruments for the Years 2012, 2021 & 2027

Table 55: Japan Recent Past, Current & Future Analysis for
Tissue Diagnostics by Technology - Immunohistochemistry, in
Situ Hybridization, Special Staining and Digital Pathology &
Workflow - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 56: Japan Historic Review for Tissue Diagnostics by
Technology - Immunohistochemistry, in Situ Hybridization,
Special Staining and Digital Pathology & Workflow Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 57: Japan 15-Year Perspective for Tissue Diagnostics by
Technology - Percentage Breakdown of Value Sales for
Immunohistochemistry, in Situ Hybridization, Special Staining
and Digital Pathology & Workflow for the Years 2012, 2021 &
2027

Table 58: Japan Recent Past, Current & Future Analysis for
Tissue Diagnostics by End-Use - Hospitals, Pharma Companies,
Research Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 59: Japan Historic Review for Tissue Diagnostics by
End-Use - Hospitals, Pharma Companies, Research Laboratories
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 60: Japan 15-Year Perspective for Tissue Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Pharma Companies, Research Laboratories and Other End-Uses for
the Years 2012, 2021 & 2027

CHINA
Tissue Diagnostics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2022 (E)
Table 61: China Recent Past, Current & Future Analysis for
Tissue Diagnostics by Product - Consumables and Instruments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 62: China Historic Review for Tissue Diagnostics by
Product - Consumables and Instruments Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 63: China 15-Year Perspective for Tissue Diagnostics by
Product - Percentage Breakdown of Value Sales for Consumables
and Instruments for the Years 2012, 2021 & 2027

Table 64: China Recent Past, Current & Future Analysis for
Tissue Diagnostics by Technology - Immunohistochemistry, in
Situ Hybridization, Special Staining and Digital Pathology &
Workflow - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 65: China Historic Review for Tissue Diagnostics by
Technology - Immunohistochemistry, in Situ Hybridization,
Special Staining and Digital Pathology & Workflow Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 66: China 15-Year Perspective for Tissue Diagnostics by
Technology - Percentage Breakdown of Value Sales for
Immunohistochemistry, in Situ Hybridization, Special Staining
and Digital Pathology & Workflow for the Years 2012, 2021 &
2027

Table 67: China Recent Past, Current & Future Analysis for
Tissue Diagnostics by End-Use - Hospitals, Pharma Companies,
Research Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 68: China Historic Review for Tissue Diagnostics by
End-Use - Hospitals, Pharma Companies, Research Laboratories
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 69: China 15-Year Perspective for Tissue Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Pharma Companies, Research Laboratories and Other End-Uses for
the Years 2012, 2021 & 2027

EUROPE
Tissue Diagnostics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2022 (E)
Table 70: Europe Recent Past, Current & Future Analysis for
Tissue Diagnostics by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 71: Europe Historic Review for Tissue Diagnostics by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 72: Europe 15-Year Perspective for Tissue Diagnostics by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2021 & 2027

Table 73: Europe Recent Past, Current & Future Analysis for
Tissue Diagnostics by Product - Consumables and Instruments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 74: Europe Historic Review for Tissue Diagnostics by
Product - Consumables and Instruments Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 75: Europe 15-Year Perspective for Tissue Diagnostics by
Product - Percentage Breakdown of Value Sales for Consumables
and Instruments for the Years 2012, 2021 & 2027

Table 76: Europe Recent Past, Current & Future Analysis for
Tissue Diagnostics by Technology - Immunohistochemistry, in
Situ Hybridization, Special Staining and Digital Pathology &
Workflow - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 77: Europe Historic Review for Tissue Diagnostics by
Technology - Immunohistochemistry, in Situ Hybridization,
Special Staining and Digital Pathology & Workflow Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 78: Europe 15-Year Perspective for Tissue Diagnostics by
Technology - Percentage Breakdown of Value Sales for
Immunohistochemistry, in Situ Hybridization, Special Staining
and Digital Pathology & Workflow for the Years 2012, 2021 &
2027

Table 79: Europe Recent Past, Current & Future Analysis for
Tissue Diagnostics by End-Use - Hospitals, Pharma Companies,
Research Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 80: Europe Historic Review for Tissue Diagnostics by
End-Use - Hospitals, Pharma Companies, Research Laboratories
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 81: Europe 15-Year Perspective for Tissue Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Pharma Companies, Research Laboratories and Other End-Uses for
the Years 2012, 2021 & 2027

FRANCE
Tissue Diagnostics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2022 (E)
Table 82: France Recent Past, Current & Future Analysis for
Tissue Diagnostics by Product - Consumables and Instruments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 83: France Historic Review for Tissue Diagnostics by
Product - Consumables and Instruments Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 84: France 15-Year Perspective for Tissue Diagnostics by
Product - Percentage Breakdown of Value Sales for Consumables
and Instruments for the Years 2012, 2021 & 2027

Table 85: France Recent Past, Current & Future Analysis for
Tissue Diagnostics by Technology - Immunohistochemistry, in
Situ Hybridization, Special Staining and Digital Pathology &
Workflow - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 86: France Historic Review for Tissue Diagnostics by
Technology - Immunohistochemistry, in Situ Hybridization,
Special Staining and Digital Pathology & Workflow Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 87: France 15-Year Perspective for Tissue Diagnostics by
Technology - Percentage Breakdown of Value Sales for
Immunohistochemistry, in Situ Hybridization, Special Staining
and Digital Pathology & Workflow for the Years 2012, 2021 &
2027

Table 88: France Recent Past, Current & Future Analysis for
Tissue Diagnostics by End-Use - Hospitals, Pharma Companies,
Research Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 89: France Historic Review for Tissue Diagnostics by
End-Use - Hospitals, Pharma Companies, Research Laboratories
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 90: France 15-Year Perspective for Tissue Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Pharma Companies, Research Laboratories and Other End-Uses for
the Years 2012, 2021 & 2027

GERMANY
Tissue Diagnostics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Germany for 2022 (E)
Table 91: Germany Recent Past, Current & Future Analysis for
Tissue Diagnostics by Product - Consumables and Instruments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 92: Germany Historic Review for Tissue Diagnostics by
Product - Consumables and Instruments Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 93: Germany 15-Year Perspective for Tissue Diagnostics by
Product - Percentage Breakdown of Value Sales for Consumables
and Instruments for the Years 2012, 2021 & 2027

Table 94: Germany Recent Past, Current & Future Analysis for
Tissue Diagnostics by Technology - Immunohistochemistry, in
Situ Hybridization, Special Staining and Digital Pathology &
Workflow - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 95: Germany Historic Review for Tissue Diagnostics by
Technology - Immunohistochemistry, in Situ Hybridization,
Special Staining and Digital Pathology & Workflow Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 96: Germany 15-Year Perspective for Tissue Diagnostics by
Technology - Percentage Breakdown of Value Sales for
Immunohistochemistry, in Situ Hybridization, Special Staining
and Digital Pathology & Workflow for the Years 2012, 2021 &
2027

Table 97: Germany Recent Past, Current & Future Analysis for
Tissue Diagnostics by End-Use - Hospitals, Pharma Companies,
Research Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 98: Germany Historic Review for Tissue Diagnostics by
End-Use - Hospitals, Pharma Companies, Research Laboratories
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 99: Germany 15-Year Perspective for Tissue Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Pharma Companies, Research Laboratories and Other End-Uses for
the Years 2012, 2021 & 2027

ITALY
Table 100: Italy Recent Past, Current & Future Analysis for
Tissue Diagnostics by Product - Consumables and Instruments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 101: Italy Historic Review for Tissue Diagnostics by
Product - Consumables and Instruments Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 102: Italy 15-Year Perspective for Tissue Diagnostics by
Product - Percentage Breakdown of Value Sales for Consumables
and Instruments for the Years 2012, 2021 & 2027

Table 103: Italy Recent Past, Current & Future Analysis for
Tissue Diagnostics by Technology - Immunohistochemistry, in
Situ Hybridization, Special Staining and Digital Pathology &
Workflow - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 104: Italy Historic Review for Tissue Diagnostics by
Technology - Immunohistochemistry, in Situ Hybridization,
Special Staining and Digital Pathology & Workflow Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 105: Italy 15-Year Perspective for Tissue Diagnostics by
Technology - Percentage Breakdown of Value Sales for
Immunohistochemistry, in Situ Hybridization, Special Staining
and Digital Pathology & Workflow for the Years 2012, 2021 &
2027

Table 106: Italy Recent Past, Current & Future Analysis for
Tissue Diagnostics by End-Use - Hospitals, Pharma Companies,
Research Laboratories and Other End-Uses - Independent Analysis
of Annual Sales in US$ Million for the Years 2020 through 2027
and % CAGR

Table 107: Italy Historic Review for Tissue Diagnostics by
End-Use - Hospitals, Pharma Companies, Research Laboratories
and Other End-Uses Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 108: Italy 15-Year Perspective for Tissue Diagnostics by
End-Use - Percentage Breakdown of Value Sales for Hospitals,
Pharma Companies, Research Laboratories and Other End-Uses for
the Years 2012, 2021 & 2027

UNITED KINGDOM
Tissue Diagnostics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United Kingdom for 2022 (E)
Table 109: UK Recent Past, Current & Future Analysis for Tissue
Diagnostics by Product - Consumables and Instruments -
Independent Analysis of Annual Sales in US$ Million for the
Years 2020 through 2027 and % CAGR

Table 110: UK Historic Review for Tissue Diagnostics by Product -
Consumables and Instruments Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2012 through 2019 and %
CAGR

Table 111: UK 15-Year Perspective for Tissue Diagnostics by
Product - Percentage Breakdown of Value Sales for Consumables
and Instruments for the Years 2012, 2021 & 2027

Table 112: UK Recent Past, Current & Future Analysis for Tissue
Diagnostics by Technology - Immunohistochemistry, in Situ
Hybridization, Special Staining and Digital Pathology &
Workflow - Independent Analysis of Annual Sales in US$ Million
for the Years 2020 through 2027 and % CAGR

Table 113: UK Historic Review for Tissue Diagnostics by
Technology - Immunohistochemistry, in Situ Hybridization,
Special Staining and Digital Pathology & Workflow Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 114: UK 15-Year Perspective for Tissue Diagnostics by
Technology - Percentage Breakdown of Value Sales for
Immunohistochemistry, in Situ Hybridization, Special Staining
and Digital Pathology & Workflow for the Years 2012, 2021 &
2027

Table 115: UK Recent Past, Current & Future Analysis for Tissue
Diagnostics by End-Use - Hospitals, Pharma Companies, Research
Laboratories and Other End-Uses - Independent Analysis of
Annual Sales in US$ Million for the Years 2020 through 2027 and
% CAGR

Table 116: UK Historic Review for Tissue Diagnostics by End-Use -
Hospitals, Pharma Companies, Research Laboratories and Other
End-Uses Markets - Independent Analysis of Annual Sales in US$

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05799811/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001